BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1008 related articles for article (PubMed ID: 31629743)

  • 1. Impact of Pre-Existing and New-Onset Atrial Fibrillation on Outcomes After Transcatheter Aortic Valve Replacement.
    Mentias A; Saad M; Girotra S; Desai M; Elbadawi A; Briasoulis A; Alvarez P; Alqasrawi M; Giudici M; Panaich S; Horwitz PA; Jneid H; Kapadia S; Vaughan Sarrazin M
    JACC Cardiovasc Interv; 2019 Nov; 12(21):2119-2129. PubMed ID: 31629743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, Management, and Associated Clinical Outcomes of New-Onset Atrial Fibrillation Following Transcatheter Aortic Valve Replacement: An Analysis From the STS/ACC TVT Registry.
    Vora AN; Dai D; Matsuoka R; Harrison JK; Hughes GC; Sherwood MW; Piccini JP; Bhardwaj B; Lopes RD; Cohen D; Holmes DR; Thourani VH; Peterson E; Kirtane A; Kapadia S; Vemulapalli S
    JACC Cardiovasc Interv; 2018 Sep; 11(17):1746-1756. PubMed ID: 30190063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and Impact of Atrial Fibrillation in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: An Analysis From the SOURCE XT Prospective Multicenter Registry.
    Tarantini G; Mojoli M; Windecker S; Wendler O; Lefèvre T; Saia F; Walther T; Rubino P; Bartorelli AL; Napodano M; D'Onofrio A; Gerosa G; Iliceto S; Vahanian A
    JACC Cardiovasc Interv; 2016 May; 9(9):937-46. PubMed ID: 27085579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of pre-existing or new-onset atrial fibrillation on 30-day clinical outcomes following transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial.
    Hengstenberg C; Chandrasekhar J; Sartori S; Lefevre T; Mikhail G; Meneveau N; Tron C; Jeger R; Kupatt C; Vogel B; Farhan S; Sorrentino S; Sharma M; Snyder C; Husser O; Boekstegers P; Hambrecht R; Widder J; Hildick-Smith D; De Carlo M; Wijngaard P; Deliargyris E; Bernstein D; Baber U; Mehran R; Anthopoulos P; Dangas G;
    Catheter Cardiovasc Interv; 2017 Nov; 90(6):1027-1037. PubMed ID: 28493641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of cardiovascular mortality, bleeding, vascular and cerebrovascular events in patients with atrial fibrillation vs. sinus rhythm undergoing transfemoral Transcatheter Aortic Valve Implantation (TAVR).
    Herold J; Herold-Vlanti V; Sherif M; Luani B; Breyer C; Bonaventura K; Braun-Dullaeus R
    BMC Cardiovasc Disord; 2017 Dec; 17(1):298. PubMed ID: 29262768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-Year Clinical Outcomes in Women After Transcatheter Aortic Valve Replacement: Results From the First WIN-TAVI Registry.
    Chieffo A; Petronio AS; Mehilli J; Chandrasekhar J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Tchetche D; Iadanza A; Sardella G; Van Mieghem NM; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail G; Sharma S; Ferrer MC; Naber C; Kievit P; Baber U; Snyder C; Sharma M; Morice MC; Mehran R;
    JACC Cardiovasc Interv; 2018 Jan; 11(1):1-12. PubMed ID: 29301640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants and Impact of Heart Failure Readmission Following Transcatheter Aortic Valve Replacement.
    Auffret V; Bakhti A; Leurent G; Bedossa M; Tomasi J; Belhaj Soulami R; Verhoye JP; Donal E; Galli E; Loirat A; Sharobeem S; Sost G; Le Guellec M; Boulmier D; Le Breton H
    Circ Cardiovasc Interv; 2020 Jul; 13(7):e008959. PubMed ID: 32600108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Outcomes in Patients With New Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement.
    Chamandi C; Barbanti M; Munoz-Garcia A; Latib A; Nombela-Franco L; Gutiérrez-Ibanez E; Veiga-Fernandez G; Cheema AN; Cruz-Gonzalez I; Serra V; Tamburino C; Mangieri A; Colombo A; Jiménez-Quevedo P; Elizaga J; Laughlin G; Lee DH; Garcia Del Blanco B; Rodriguez-Gabella T; Marsal JR; Côté M; Philippon F; Rodés-Cabau J
    JACC Cardiovasc Interv; 2018 Feb; 11(3):301-310. PubMed ID: 29413244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of atrial fibrillation on outcomes in patients who underwent transcatheter aortic valve replacement.
    Maan A; Heist EK; Passeri J; Inglessis I; Baker J; Ptaszek L; Vlahakes G; Ruskin JN; Palacios I; Sundt T; Mansour M
    Am J Cardiol; 2015 Jan; 115(2):220-6. PubMed ID: 25465936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of atrial fibrillation in patients with chronic kidney disease undergoing transcatheter aortic valve replacement: Insights of the Healthcare Cost and Utilization Project's National Inpatient Sample.
    Cheung A; Lima FV; Yen TYM; Parikh P; Butler J; Gruberg L
    Cardiovasc Revasc Med; 2018 Jan; 19(1 Pt A):21-25. PubMed ID: 29276175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline Characteristics and Prognostic Implications of Pre-Existing and New-Onset Atrial Fibrillation After Transcatheter Aortic Valve Implantation: Results From the FRANCE-2 Registry.
    Chopard R; Teiger E; Meneveau N; Chocron S; Gilard M; Laskar M; Eltchaninoff H; Iung B; Leprince P; Chevreul K; Prat A; Lievre M; Leguerrier A; Donzeau-Gouge P; Fajadet J; Mouillet G; Schiele F;
    JACC Cardiovasc Interv; 2015 Aug; 8(10):1346-1355. PubMed ID: 26315738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfemoral TAVR in Nonagenarians: From the CENTER Collaboration.
    Vlastra W; Chandrasekhar J; Vendrik J; Gutierrez-Ibanes E; Tchétché D; de Brito FS; Barbanti M; Kornowski R; Latib A; D'Onofrio A; Ribichini F; Baan J; Tijssen JGP; Pan M; Dumonteil N; Mangione JA; Sartori S; D'Errigo P; Tarantini G; Lunardi M; Orvin K; Pagnesi M; Sanchez Gila J; Modine T; Dangas G; Mehran R; Piek JJ; Delewi R
    JACC Cardiovasc Interv; 2019 May; 12(10):911-920. PubMed ID: 31122347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, Prognostic Impact, and Predictive Factors of Readmission for Heart Failure After Transcatheter Aortic Valve Replacement.
    Durand E; Doutriaux M; Bettinger N; Tron C; Fauvel C; Bauer F; Dacher JN; Bouhzam N; Litzler PY; Cribier A; Eltchaninoff H
    JACC Cardiovasc Interv; 2017 Dec; 10(23):2426-2436. PubMed ID: 29217006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal changes of new-onset atrial fibrillation in patients randomized to surgical or transcatheter aortic valve replacement.
    Jørgensen TH; Thyregod HG; Tarp JB; Svendsen JH; Søndergaard L
    Int J Cardiol; 2017 May; 234():16-21. PubMed ID: 28258844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left Ventricular Hypertrophy Does Not Affect 1-Year Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Varshney AS; Manandhar P; Vemulapalli S; Kirtane AJ; Mathew V; Shah B; Lowenstern A; Kosinski AS; Kaneko T; Thourani VH; Bhatt DL
    JACC Cardiovasc Interv; 2019 Feb; 12(4):373-382. PubMed ID: 30784643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes Following Urgent/Emergent Transcatheter Aortic Valve Replacement: Insights From the STS/ACC TVT Registry.
    Kolte D; Khera S; Vemulapalli S; Dai D; Heo S; Goldsweig AM; Aronow HD; Elmariah S; Inglessis I; Palacios IF; Thourani VH; Sharaf BL; Gordon PC; Abbott JD
    JACC Cardiovasc Interv; 2018 Jun; 11(12):1175-1185. PubMed ID: 29929641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of urgent versus nonurgent transcatheter aortic valve replacement.
    Elbadawi A; Elgendy IY; Mentias A; Saad M; Mohamed AH; Choudhry MW; Ogunbayo GO; Gilani S; Jneid H
    Catheter Cardiovasc Interv; 2020 Jul; 96(1):189-195. PubMed ID: 31647180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Chronic Kidney Disease With In-Hospital Outcomes of Transcatheter Aortic Valve Replacement.
    Gupta T; Goel K; Kolte D; Khera S; Villablanca PA; Aronow WS; Bortnick AE; Slovut DP; Taub CC; Kizer JR; Pyo RT; Abbott JD; Fonarow GC; Rihal CS; Garcia MJ; Bhatt DL
    JACC Cardiovasc Interv; 2017 Oct; 10(20):2050-2060. PubMed ID: 29050621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computed tomography predictors of mortality, stroke and conduction disturbances in women undergoing TAVR: A sub-analysis of the WIN-TAVI registry.
    Spaziano M; Chieffo A; Watanabe Y; Chandrasekhar J; Sartori S; Lefèvre T; Petronio AS; Presbitero P; Tchetche D; Iadanza A; Van Mieghem NM; Mehilli J; Mehran R; Morice MC;
    J Cardiovasc Comput Tomogr; 2018; 12(4):338-343. PubMed ID: 29735255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and Outcomes of Mitral Stenosis in Patients Undergoing Transcatheter Aortic Valve Replacement: Findings From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapies Registry.
    Joseph L; Bashir M; Xiang Q; Yerokun BA; Matsouaka RA; Vemulapalli S; Kapadia S; Cigarroa JE; Zahr F
    JACC Cardiovasc Interv; 2018 Apr; 11(7):693-702. PubMed ID: 29622149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.